Shivering Clinical Trial
Official title:
Comparing Dexmedetomidine, Ketamine and Dexmetedomidine-Ketamine Combination to Control Shivering During Regional Anaethesia
Shivering is defined as an involuntary, repetitive activity of skeletal muscles. The incidence of shivering has been found to be quite high, approximately 40-50% in different studies. It can double or even triple oxygen consumption and carbon dioxide production. Shivering also increase intraocular and intracranial pressure, and may contribute to increased wound pain, delayed wound healing, and delayed discharge from post-anaesthetic care. Apart from being an uncomfortable experience, its deleterious effects deserve primary prevention and rapid control on occurence.
Shivering is a physiological response to core hypothermia in an attempt to raise the
metabolic heat production. The main causes of intra and postoperative shivering are heat
loss, increased sympathetic tone, pain, and systemic release of pyrogens. Spinal anaesthesia
significantly impairs the thermoregulation system by inhibiting tonic vasoconstriction, which
plays a significant role in temperature regulation. It also causes a redistribution of core
heat from the trunk (below the block level) to the peripheral tissues. These factors
predispose patients to hypothermia and shivering.
The treatment of shivering includes both pharmacological and non-pharmacological methods. The
non-pharmacological management is by external heating like the use of forced air warming,
warming blankets, warmed fluids etc.
According to the results of meta-analysis, the most frequently reported pharmacological
interventions include clonidine, pethidine, tramadol, nefopam, and ketamine. Unfortunately,
no gold standard treatment is known for shivering as the administration of all the available
drugs is associated with various adverse effects.
Dexmedetomidine, a congener of clonidine, is a highly selective adrenoceptor agonist. It has
been used as a sedative agent and is known to reduce the shivering threshold. Few studies
which have explored its anti-shivering potential have inferred that dexmedetomidine is an
effective drug without any major adverse effect and provides good haemodynamic stability.
Ketamine has been tried to prevent shivering during anaesthesia with good results. Ketamine a
competitive NMDA receptor antagonist has a role in thermoregulation at various levels. NMDA
receptor modulates non-adrenergic and serotoninergic neurons in locus coeruleus. It is used
as anti-shivering agent.
Shivering is a physiological response to core hypothermia in an attempt to raise the
metabolic heat production. The main causes of intra and postoperative shivering are heat
loss, increased sympathetic tone, pain, and systemic release of pyrogens. Spinal anaesthesia
significantly impairs the thermoregulation system by inhibiting tonic vasoconstriction, which
plays a significant role in temperature regulation. It also causes a redistribution of core
heat from the trunk (below the block level) to the peripheral tissues. These factors
predispose patients to hypothermia and shivering.
The treatment of shivering includes both pharmacological and non-pharmacological methods. The
non-pharmacological management is by external heating like the use of forced air warming,
warming blankets, warmed fluids etc.
According to the results of meta-analysis, the most frequently reported pharmacological
interventions include clonidine, pethidine, tramadol, nefopam, and ketamine. Unfortunately,
no gold standard treatment is known for shivering as the administration of all the available
drugs is associated with various adverse effects.
Dexmedetomidine, a congener of clonidine, is a highly selective adrenoceptor agonist. It has
been used as a sedative agent and is known to reduce the shivering threshold. Few studies
which have explored its anti-shivering potential have inferred that dexmedetomidine is an
effective drug without any major adverse effect and provides good haemodynamic stability.
Ketamine has been tried to prevent shivering during anaesthesia with good results. Ketamine a
competitive NMDA receptor antagonist has a role in thermoregulation at various levels. NMDA
receptor modulates non-adrenergic and serotoninergic neurons in locus coeruleus. It is used
as anti-shivering agent.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04730609 -
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
|
Phase 4 | |
Completed |
NCT02141412 -
Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia
|
Phase 4 | |
Not yet recruiting |
NCT06283771 -
The Effect of Heated Socks Developed With Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering
|
N/A | |
Completed |
NCT02436174 -
Assessment Of Shivering With iSeismograph
|
N/A | |
Completed |
NCT03721432 -
The Effect of Oral Pregabalin on Epidural-induced Shivering and Epidural Characteristics
|
N/A | |
Not yet recruiting |
NCT03530007 -
Anti-shivering Effect of Ondansetron
|
Phase 2/Phase 3 | |
Completed |
NCT03679065 -
Prophylactic Paracetamol or Dexamethasone for Post-spinal Anesthesia Shivering
|
Phase 4 | |
Completed |
NCT03675555 -
Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering
|
Phase 4 | |
Completed |
NCT03679052 -
Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering
|
Phase 4 | |
Recruiting |
NCT04938219 -
Shivering_Basel_Baden
|
N/A | |
Active, not recruiting |
NCT05284409 -
Comparative Study Between the Prophylactic Intravenous Administrations of Acetaminophen vs Dexamethasone vs Pethidine Regarding the Incidence of Shivering Induced by Single Shot Spinal Anesthesia in the Orthopedic Surgeries of the Lower Limbs
|
Phase 4 | |
Recruiting |
NCT03157648 -
Relationship Between Core-peripheral Temperature Difference and Shivering Symptom in Patients in PACU
|
N/A | |
Terminated |
NCT03497507 -
Investigating the Effect of Acupressure on Shivering During a Cesarean Delivery in Women Who Were Previously Laboring With an Epidural
|
N/A | |
Completed |
NCT03370562 -
Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering
|
N/A | |
Completed |
NCT05110469 -
Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia
|
Phase 4 | |
Not yet recruiting |
NCT03566628 -
Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography
|
N/A | |
Completed |
NCT02967601 -
Influence of Preoperative Anxiety on Shivering During Elective Caesarean Section Under Spinal Anaesthesia
|
N/A | |
Recruiting |
NCT05765162 -
Safe Brain Initiative, Operationalizing Precision Anaesthesia
|
||
Recruiting |
NCT04870541 -
Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.
|
Phase 4 | |
Active, not recruiting |
NCT01669213 -
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension
|
N/A |